Please ensure Javascript is enabled for purposes of website accessibility

Tag Archives: Viela Bio

Viela Bio begins clinical trials months after $250M spinoff (access required)

One of Maryland’s best-funded biotech companies took a milestone first step Monday, announcing it has begun clinical trials of a medication it is developing. Gaithersburg-based Viela Bio was spun out of MedImmune, a subsidiary of AstraZeneca, last month with $250 million in ...

Read More »

Md. continues venture capital momentum with $405 million in Q1 (access required)

Maryland companies continued last year’s strong performance in receiving venture capital investments, sparked by the large Viela Bio deal, according to the quarterly MoneyTree Report from PricewaterhouseCoopers LLP and CB Insights. With more than $405 million invested last quarter, Maryland ...

Read More »

With $250M from investors, Viela Bio out on its own (access required)

MedImmune spun out Viela Bio as an independent biotechnology company with $250 million in Series A financing and six potential medicines, the companies announced Wednesday. Viela Bio will be based in Gaithersburg and will focus on inflammation and autoimmunity biologics, ...

Read More »